S ZGLICZYNSKI
Overview
Explore the profile of S ZGLICZYNSKI including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milewicz A, Szymanski W, Ruzyllo W, ZGLICZYNSKI S, Reinfus M, Zielinski J, et al.
Gynecol Endocrinol
. 2003 Feb;
16(5):385-9.
PMID: 12587533
Women surviving breast cancer in the postmenopausal period suffer from hormonal alternations with adverse effect on mental status and functioning of a number of organs and systems. Two thirds of...
2.
Jastrzebska H, ZGLICZYNSKI S, Czech W, Lewartowska A, Debski R
Wiad Lek
. 2002 Aug;
54 Suppl 1:389-97.
PMID: 12182055
Unlabelled: The aim of the study was to estimate the dose of thyroxine required by pregnant women who had undergone total thyreoidectomy and radioiodine treatment for thyroid cancer. Material consisted...
3.
Jastrzebska H, ZGLICZYNSKI S
Wiad Lek
. 2002 Aug;
54 Suppl 1:383-8.
PMID: 12182054
Total thyroidectomy followed by 131I ablation and thyroxine suppressive therapy is recommended for the treatment of differentiated thyroid carcinomas. Thyroxine should be given at a dose sufficient to suppress TSH...
4.
Krassowski J, Gabryelewicz M, Jeske W, ZGLICZYNSKI S
Pol Merkur Lekarski
. 2000 Nov;
8(49):481-2.
PMID: 11070721
A typical three generation-family with MEN 2A (Multiple Endocrine Neoplasia, Type 2A) is described. Two brothers and their uncle were affected with medullary thyroid carcinoma (MTC) and pheochromocytoma. The diagnosis...
5.
Kozakowski J, Adamkiewicz M, Krassowski J, ZGLICZYNSKI S
Pol Merkur Lekarski
. 1999 Jun;
6(33):131-4.
PMID: 10365596
Unlabelled: The relationship of growth hormone (GH) to the ageing process is currently subject of considerably interest. The study was designed to investigate the effects of replacement therapy with growth...
6.
Kozakowski J, Papierska L, Krassowski J, ZGLICZYNSKI S
Pol Arch Med Wewn
. 1999 May;
100(4):306-12.
PMID: 10335039
Objective: Decline in growth hormone (GH) secretion and serum levels of insulin-like growth factor-1 (IGF-1) during ageing may be a causal factor in the development of osteopenia. The purpose of...
7.
Rabijewski M, Adamkiewicz M, ZGLICZYNSKI S
Pol Arch Med Wewn
. 1999 May;
100(3):212-21.
PMID: 10335026
The aim of this study was to determine the influence of testosterone replacement therapy in elderly men on mood, bone mineral density, and lipids. We investigated thirty men (mean +/-...
8.
Krassowski J, Zgliczynski W, Jeske W, ZGLICZYNSKI S
J Clin Endocrinol Metab
. 1999 May;
84(5):1761-2.
PMID: 10323416
No abstract available.
9.
Krassowski J, ROGALA H, Jeske W, ZGLICZYNSKI S
Horm Metab Res
. 1996 Apr;
28(4):207-8.
PMID: 8740200
No abstract available.
10.
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
ZGLICZYNSKI S, Ossowski M, Slowinska-Srzednicka J, Brzezinska A, Zgliczynski W, Soszynski P, et al.
Atherosclerosis
. 1996 Mar;
121(1):35-43.
PMID: 8678922
We investigated the effects of long-term testosterone replacement in hypogonadal and elderly men on lipids and lipoproteins. Twenty-two men with initial serum testosterone concentrations below 3.5 ng/ml took part in...